Home Details
| Official Symbol of Gene | CD80 |
| Species | Homo sapiens |
| Entrez Gene ID | 941 |
| Official Full Name | CD80 molecule |
| Also known as | B7; BB1; B7-1; B7.1; LAB7; CD28LG; CD28LG1 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000121594 MIM:112203; AllianceGenome:HGNC:1700 |
| Map Location | 3q13.33 |
| Drug | Cladribine treatment |
| Interaction Type | activator |
| Descent | N/A |
| Disease | MS |
| Pubmed ID | 35734180 |
| Year | 2022 |
| Title | Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation |
| Result | In addition, MDMs treated with cladribine showed increased expression of costimulatory molecules CD80 and CD40, as well as expression of anti-inflammatory, pro-trophic genes IL10 and MERTK, depending on the differentiation condition. Cladribine treatment in vitro. |
| Mechanism/pathway | N/A |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.